FMR LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 60,063 0.400% | -594,377 (-90.82%) | Filing |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 654,440 14.999% | 174,017 (+36.22%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 480,423 11.173% | -10,502 (-2.14%) | Filing |
| 2023-02-10 09:08 am Purchase | 2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 490,925 11.571% | 121,898 (+33.03%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 369,027 8.698% | -28,811 (-7.24%) | Filing |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 397,838 10.762% | 116,734 (+41.53%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 281,104 7.611% | 281,104 (New Position) | Filing |